Navigation Links
Excess Drinking Boosts Cardiovascular Disease Risk
Date:5/14/2008

Especially for women, heavy consumption tied to arterial stiffening, enlarged hearts

WEDNESDAY, May 14 (HealthDay News) -- While research suggests that moderate alcohol consumption may have health benefits, heavy drinking increases blood pressure, stiffens blood vessels and causes more rigid heart muscles in men and enlarged hearts in women -- all risk factors for cardiovascular disease, a new study warns.

Men who drink more than 21 units of alcohol per week and women who drink more than 14 units of alcohol a week put themselves at serious risk for hypertensive heart disease, heart failure and stroke, the researchers found.

"These shocking findings illustrate the extreme risks that heavy drinkers are exposing themselves to -- some of which are particularly pronounced in women," lead investigator Dr. Azra Mahmud, a cardiovascular lecturer and hypertension specialist at the Trinity Centre for Health Science, St. James Hospital, Dublin, Ireland, said in a prepared statement.

"We want to make sure people aren't getting mixed messages about alcohol. The potentially fatal effects of heavy drinking may more than counteract the well-documented benefits of sensible alcohol intake," Mahmud said.

The study included 100 women and 100 men (mean age 46, all healthy) who were divided into three groups: non-drinkers, moderate drinkers (males, less than 21 units of alcohol per week; females, less than 14 units per week) and heavy drinkers (males, more than 21 units per week; females, more than 14 units per week).

The participants underwent a number of tests including ultrasound of heart to assess arterial stiffness and pulse wave velocity to measure aortic blood pressures and wave reflections in the aorta.

The results showed that heavy drinking is associated with arterial stiffening and impaired left ventricular (LV) relaxation in males, and LV structural changes, including LV enlargement (hypertrophy), in females. Of special note, women who were heavy drinkers had an enlarged heart even without high blood pressure or stiff arteries.

"The excessive consumption of alcohol causes significant arterial and ventricular stiffening and an enlarged heart; factors associated with poor cardiovascular outcomes in hypertensive populations," Mahmud said. "Trends in heavy drinking continue to rise, and it is high time to recognize the potential of an alcohol-induced epidemic of cardiovascular disease. Binge and heavy drinkers must consider their behavior and control their intake before it's too late."

The study was expected to be presented Wednesday at the American Society of Hypertension annual meeting, in New Orleans.

Cardiovascular disease (CVD) is the leading cause of death worldwide. About 17.5 million people die from CVD each year, and that toll could increase to almost 20 million by 2015.

More information

The U.S. National Heart, Lung, and Blood Institute has more about heart and vascular diseases.



-- Robert Preidt



SOURCE: American Society of Hypertension, news release, May 14, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. U.S. Health Club Members Proclaim - I Lost It at the Club! and Lose 45 Tons of Excess Weight
2. New study sheds light on excessive drinking among the elderly
3. Novel link between excessive nutrient levels and insulin resistance
4. Excessive overtriage in US trauma centers overwhelming system resources, delaying patient care
5. Connecticut Trial Lawyers Ask Doctors to Question Insurers Excess Profits
6. Excess Pounds Raise Womens Cancer Risk
7. Landmark Report: Excess Body Fat Causes Cancer
8. Vanda Pharmaceuticals VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties
9. Challenge Tops 848,000 lbs, Urges Oaklanders to Team Up to Fight Epidemic of Excess Weight
10. Study: Modafinil is effective in treating excessive sleepiness
11. New tool to assess excessive daytime sleepiness in adolescents published in JCSM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... , ... August 18, 2017 , ... The Golseth Agency, ... the Dallas/Fort Worth area, is spearheading a regional charity campaign organized to provide support ... In early June of this year, Christina and her children returned from out of ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... highly trained practitioners specializing in bioidentical hormone replacement therapy and integrative medicine, has ... imbalance and conditions of aging, such as menopause, andropause, thyroid disorder and adrenal ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage ... up its marketing efforts with its product now available through Jet.com. , After ... public. The effervescent powdered drink is designed to quickly detox the body thereby avoiding ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... numbers and call tracking and monitoring solutions, announced today the launch of a ... include a modern navigation and aesthetic, fully responsive design, and an enhanced search ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Dangerous Inheritance”: a mystery about ... Winters. Diane is from Southwest Nebraska where she was raised on a farm. ... The story is fictional, but the friendships and mantra of ‘neighbors helping neighbors’ ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... -- Axium Pharmaceuticals Inc., the creator of the drug Truveta for ... of an IPO. The United States ... of a prescription epilepsy drug being $450.00-$1200.00 for a one month supply. ... AXIUM PHARMACEUTICALS, INC ... staggering figure is the fact that Americans spent $42 billion on anxiety ...
(Date:8/14/2017)... Israel , Aug. 15, 2017  BrainStorm ... adult stem cell technologies for neurodegenerative diseases, announced financial ... "We are in ... 3 trial to investigate NurOwn ® in ALS," ... Officer of BrainStorm. "We have agreements with Mass. General ...
(Date:8/8/2017)... -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused ... for the second quarter ended June 30, 2017. ... and to date: ... Company,s lead project, BL-8040: Announced plans ... novel stem cell mobilization treatment for autologous bone-marrow transplantation ...
Breaking Medicine Technology: